Fundraising Fox
Bernard Gilly
InvestorFounderChairman at iBionext · Founder at Gensight Biologics S.A
Paris, Île-de-France, France
FoundedGensight Biologics S.A
Find your path to Bernard
Sign up to see every warm intro you have to Bernard
- Paths you didn't know you had: your email and LinkedIn already hold routes to Bernard. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Bernard Gilly is CEO of BrainEver, a biopharmaceutical company developing therapeutic solutions for age-related neurodegenerative diseases including ALS and Parkinson's disease, with preclinical studies planned to advance to clinical trials by 2025. He is also president of Ibionext, an investment fund founded in 2012 that backs biotech and medtech companies. His background includes co-founding Gensight Biologics and Fovea Pharmaceuticals (sold to Sanofi for €370 million), serving as president and CEO of Transgene during its public listing on Euronext and Nasdaq in 1998, and working as a partner at Sofinnova Partners from 2000 to 2005.
Contact· self-published, not guessed
Founder at Gensight Biologics S.A
Intro paths
In turn, Bernard can intro founders to Gensight Biologics S.A's investors below.
Gensight Biologics S.A's investors · 3
Colleagues at iBionext
Frequently asked questions
- Who is Bernard Gilly?
- Bernard Gilly is CEO of BrainEver, a biopharmaceutical company developing therapeutic solutions for age-related neurodegenerative diseases including ALS and Parkinson's disease, with preclinical studies planned to advance to clinical trials by 2025. He is also president of Ibionext, an investment fund founded in 2012 that backs biotech and medtech companies. His background includes co-founding Gensight Biologics and Fovea Pharmaceuticals (sold to Sanofi for €370 million), serving as president and CEO of Transgene during its public listing on Euronext and Nasdaq in 1998, and working as a partner at Sofinnova Partners from 2000 to 2005.
- Where does Bernard Gilly work?
- Bernard Gilly is Founder of Gensight Biologics S.A and Chairman at iBionext.
- What companies did Bernard Gilly found?
- Bernard Gilly founded Gensight Biologics S.A.
Founder mafias
Sofinnova Partners mafia15
Also came through, then founded or led a company.
Sofinnova Partners mafia13
Also came through, then founded or led a company.
About this profile. Compiled from public sources — iBionext's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights